AstraZeneca Study Finds Vaccine to Be 79% Effective
AstraZeneca’s COVID-19 vaccine could be authorized for emergency use in the U.S. soon.
The pharmaceutical company just released data from its U.S. stage-three vaccine trial.
AstraZeneca says it’s vaccine is 79% effective at preventing symptomatic COVID-19 cases.
It was also found to be 100% effective at preventing severe disease and hospitalization.
AstraZeneca plans to apply for emergency use authorization from the Food and Drug Administration in the coming weeks.